U.S. Markets close in 5 hrs 11 mins

Strength Seen in Enanta Pharmaceuticals (ENTA): Stock Soars 28.6%

Zacks Equity Research

Enanta Pharmaceuticals, Inc. (ENTA) was a big mover last session, as the company saw its shares rise by roughly 29% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up almost 91% in the past one-month time frame.

This biotechnology company has seen one positive revision over the last 30 days and its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Enanta Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if this recent move higher can turn into more strength down the road.

Enanta Pharmaceuticals currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Other stocks in the med-drugs industry looking equally good are Forest Laboratories Inc. (FRX), Jazz Pharmaceuticals plc (JAZZ), and Lannett Company, Inc. (LCI). All these stocks carry the same Zacks Rank as BioSpecifics Technologies.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

(ENTA): Free Stock Analysis Report

FOREST LABS INC (FRX): Free Stock Analysis Report

(JAZZ): Free Stock Analysis Report

LANNETT CO INC (LCI): Free Stock Analysis Report

Zacks Investment Research